IKARIA, - now a part of Mallinckrodt Pharmaceuticals. Revenue

Pharmaceutical Manufacturing • Franklin, New Jersey, United States • 51-100 Employees

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. revenue & valuation

Annual revenue	$6,742,819
Revenue per employee	$72,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$21,600,000
Total funding	No funding

Key Contacts at IKARIA, - now a part of Mallinckrodt Pharmaceuticals.

David Trueblood

Director, Regulatory Affairs

Jo Anne Zubrickas

Director, It

Mike Berry

Director, National Accounts, Mallinckrodt, West Region, 2011- Present

Ken Abreu

Director, National Accounts & Managed Markets

Daniel Nealon

Senior Director, Qa Compliance

Company overview

Headquarters	Perryville III Corporate Park, 53 Frontage Road, Third Floor, P.O. Box 9001, Hampton, NJ 08827-9001, US
Phone number	+19082386600
Website	mallinckrodt.com
NAICS	3254
SIC	283
Keywords	Service, Pharmaceuticals, Medical Device
Founded	2007
Employees	51-100

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. Email Formats

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@mallinckrodt.com), used 58.3% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@mallinckrodt.com	58.3%
{first name}.{last name}	john.doe@mallinckrodt.com	41.7%

About IKARIA, - now a part of Mallinckrodt Pharmaceuticals.

Mallinckrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology along with analgesics and central nervous system drugs for prescribing by office- and hospital-based physicians. The company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. The company's Specialty Brands segment includes branded medicines; its Specialty Generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing; and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. The company's fiscal 2014 revenue totaled $2.54 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com. Mission: Managing Complexity. Improving Lives. Values: Quality, Integrity, Service Principal Executive Office: Mallinckrodt plc Damastown Industrial Estate Mulhuddart, Dublin 15 Ireland U.S. Headquarters: 675 McDonnell Blvd. St. Louis, MO 63042 USA Website: www.mallinckrodt.com Stock Ticker: MNK Corporate Blog: http://blog.mallinckrodt.com/ Careers Website: www.mallinckrodt.com/careers Investor Relations: http://www.mallinckrodt.com/investors

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. has 30 employees across 8 departments.

Departments

Number of employees

Funding Data

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. has never raised funding before.

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. Tech Stack

Discover the technologies and tools that power IKARIA, - now a part of Mallinckrodt Pharmaceuticals.'s digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Windows Server

Operating systems

JavaScript graphics

Optimizely Content Management

CMS

Cloudflare

CDN

jQuery

JavaScript libraries

HSTS

Security

Google Analytics

Analytics

Microsoft ASP.NET

Web frameworks

Linkedin Insight Tag

Analytics

Imperva

CDN

Google Tag Manager

Tag managers

Frequently asked questions

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. is located in Franklin, New Jersey, US.

You can reach IKARIA, - now a part of Mallinckrodt Pharmaceuticals. at +19082386600.

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. generates an estimated annual revenue of $6,742,819. This revenue figure reflects the company's market position and business performance in its industry.

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. has an estimated valuation of $21,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. was founded in 2007, making it 19 years old. The company has established itself as a significant player in its industry over this time.

IKARIA, - now a part of Mallinckrodt Pharmaceuticals. has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.